5Przepiorka D, Keman NA, Ippoliti C, et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute-versus-host disease [ J ]. Blood,2000,95 ( 1 ) :83 - 89.
6Finke J,Sehmoor C, Lang H, et al. Matehed and mismatch allogeneic stem-cell transplantation from unrelated donors using com- bined graft-versus-host disease propilylaxis including rabbit anti-T lymphocyte globulin [ J ]. J Clin Oncol,2003,21 ( 3 ) :506 - 513.
7Carcia-Manero G,Faderl S,O'Beien S,et al.Chronic myelogenous leukemia:a review and update of therapeutic strategies[J].Cancer,2003,98(3):437-457.
8Ringden O,Remberger M,Runde V,et al.Peripheral blood setm cell transplantation from unrelated donors:a comparison with marrow transplantation[J].Blood,1999,94(2):455-464.
9Torok-Storb B,Boeckh M,Hoy C,et al.Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantion[J].Blood,1997,90(5):2097.
10Aversa F,Tabilio A,Velardi A,et al.Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype[J].N Engl J Med,1998,339(17):1186-1193.
4Wu T,Lu DP.Blood and marrow transplantation in the People's Republic of China[J].Bone Marrow Transplant.2008(Suppl 1):S73-S75.
5Vogelsang GB.How I treat chronic graft-versus-host disease[J].Blood,2001(5):1196-1201.
6Russell JA,Tumer AR,Larratt L,et al.Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease:a matched pajr analysis[J].Biol Blood Marrow Transplant,2007(3):299-306.
7Lu DP,Dong L,Wu T,et al.Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation[J].Blood,2006(8):3065-6073.
8HOWS JM, PASSWEG JR, TICHEUI A, ct al. Comparison of long-term outcomes after allogeneic hematopoietic stern cell transplantation from matched sibling and unrelated donors~J~. Bone Marrow Transptat~t, 20(1~, 38(12) ~799-805.
9JGASIA M, ARORA M, FLOWERS ME, et al. Risk factors for acute GVHD and survival after hematopoietic cell trans- plantation~J3. Blood, 2012, 119(1):296-307.
